Statements (21)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:immunotherapy
|
gptkbp:administered_by |
oral medication
|
gptkbp:approves |
gptkb:FDA
|
gptkbp:atccode |
P01 BF01
|
gptkbp:bioavailability |
approximately 30%
|
gptkbp:can_be_combined_with |
gptkb:lumefantrine
|
gptkbp:casnumber |
71963-77-4
|
gptkbp:chemical_formula |
C17 H26 O5
|
gptkbp:developed_by |
gptkb:artemisinin
gptkb:Novartis |
https://www.w3.org/2000/01/rdf-schema#label |
artemether
|
gptkbp:marketed_as |
gptkb:Coartem
|
gptkbp:mechanism_of_action |
inhibits parasite growth
|
gptkbp:side_effect |
dizziness
headache nausea vomiting |
gptkbp:used_for |
treatment of malaria
|
gptkbp:bfsParent |
gptkb:Pentacarinat
gptkb:artemisinin-based_therapies |
gptkbp:bfsLayer |
7
|